NorthCrest Asset Manangement’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.17M	Sell	5,605 -1,932	-26%	-$962K	0.1%	172
2025 Q4	$3.69M	Buy	7,537 +1,843	+32%	+$858K	0.08%	174
2025 Q3	$2.6M	Buy	5,694 +262	+5%	+$88.1K	0.06%	199
2025 Q2	$1.6M	Buy	5,432 +97	+2%	+$29K	0.04%	240
2025 Q1	$1.64M	Sell	5,335 -263	-5%	-$90.1K	0.05%	230
2024 Q4	$1.98M	Buy	5,598 +84	+2%	+$30.9K	0.06%	205
2024 Q3	$1.98M	Buy	5,514 +238	+5%	+$80.4K	0.06%	207
2024 Q2	$1.68M	Buy	5,276 +1	+0%	+$265	0.06%	214
2024 Q1	$1.21M	Sell	5,275 -60	-1%	-$13.5K	0.04%	254
2023 Q4	$1.17M	Hold	5,335	–	–	0.04%	245
2023 Q3	$1.21M	Hold	5,335	–	–	0.05%	235
2023 Q2	$1.18M	Hold	5,335	–	–	0.05%	243
2023 Q1	$1.19M	Hold	5,335	–	–	0.05%	235
2022 Q4	$1.48M	Hold	5,335	–	–	0.08%	142
2022 Q3	$1.12M	Hold	5,335	–	–	0.06%	195
2022 Q2	$1.26M	Hold	5,335	–	–	0.06%	185
2022 Q1	$957K	Buy	5,335 +80	+2%	+$15.2K	0.05%	206
2021 Q4	$1.14M	Buy	+5,255	New	+$1.03M	0.06%	205